Investegate |Curium Announcements | Curium: Curium's Phase 3 ECLIPSE Trial Starts Enrolling Patients
Investegate announcements from Curium, Curium’s Phase 3 ECLIPSE Trial Starts Enrolling Patients
Source: investegate.co.uk
📰 Accurium News
Page 3 - Accurium News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Accurium. Real-time updates on events, politics, business and more.
Curium's Phase 3 ECLIPSE Trial Starts Enrolling Patients
ST. LOUIS, May 03, 2022 (GLOBE NEWSWIRE) -- Curium announced today it has successfully enrolled and dosed patients in the ECLIPSE Trial. ECLIPSE is a Phase 3, multi-center, open-label, randomized clinical
United States Renaud Dehareng Kostenloser Wertpapierhandel Sandy Borgschulte Pierre Curie Sakir Mutevelic
Source: finanznachrichten.de
The value of advice post-RIC | Super Review
The Retirement Income Covenant (RIC) may set a benchmark when it comes to what is good practice for retirement strategy without diminishing the value offered by financial advice, according to Accurium.
South Australia Melanie Dunn Australian Prudential Regulation Authority Retirement Income Covenant Age Pension
Source: superreview.com.au
RIC to set good retirement strategy practice
The Retirement Income Covenant (RIC) may set a benchmark when it comes to what is good practice for retirement strategy without diminishing the value offered by financial advice, according to Accurium.
South Australia Melanie Dunn Australian Prudential Regulation Authority Retirement Income Covenant Age Pension
Source: moneymanagement.com.au
Curium Announces Significant Increase in Detectnet (copper Cu 64 dotatate injection) Production Capacity
ST. LOUIS, April 19, 2022 (GLOBE NEWSWIRE) -- Curium announced today that it will be increasing production capacity of Detectnet to accommodate the significant demand in the market. Curium will now be
United States Kostenloser Wertpapierhandel Sandy Borgschulte Michael Patterson Pierre Curie Michael Wessler
Source: finanznachrichten.de
Curium Announces FDA Approval of a Generic Version of DaTscan (Ioflupane I 123 Injection) in the U.S.
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) -- Curium announced today that its generic version of DaTscan (Ioflupane I 123 Injection) was approved on March 30, 2022, by the U.S. Food and Drug Administration
United States Ted Porter Kostenloser Wertpapierhandel Sandy Borgschulte Michael Patterson Datscan Ioflupane
Source: finanznachrichten.de
Accurium clarifies common area of confusion with segregated method
SMSF services provider has provided an explanation on whether an SMSF can use the segregated method where a fund that’s solely in retirement phase receives a contribution. In a live Q&A webinar, A
Source: smsfadviser.com
Monrol Signing Agreement to License its GMP Grade Lu-177 n.c.a Production Technology to Curium
Eczacibasi-Monrol Nuclear Products Co. (Monrol) has today announced it has signed an agreement with Curium Netherlands B.V (Curium) to license its GMP grade medical radioisotope, no-carrier-added 177Lu (n.c.a. 177Lu) cutting-edge production technology LuMagic®. This agreement will enable transfer of relevant equipment and supply from Monrol to Curium.
Source: businesswireindia.com
Monrol Signing Agreement to License its GMP Grade Lu-177 n.c.a Production Technology to Curium
Eczacibasi-Monrol Nuclear Products Co. (Monrol) has today announced it has signed an agreement with Curium Netherlands B.V (Curium) to license its GMP grade medical radioisotope, no-carrier-added 177Lu
Source: finanznachrichten.de
Investegate |Curium Announcements | Curium: Curium to become major player in the supply on non carrier added Lu-177
Investegate announcements from Curium, Curium to become major player in the supply on non carrier added Lu-177
Source: investegate.co.uk